SHENZHEN SIYOMICRO BIO-TECH CO LTD
中科欣扬
SHENZHEN SIYOMICRO BIO-TECH CO LTD
Biotech/Healthcare
Zhongke Xinyang has completed a Series C financing round of several hundred million RMB, which will be invested in building its synthetic biology platform and commercializing its products, expanding the boundaries of its biomanufacturing business.
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-31
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.